Crambescidin-816 acts as a fungicidal with more potency than crambescidin-800 and -830, inducing cell cycle arrest, increased cell size and apoptosis in Saccharomyces cerevisiae

Marine Drugs

Volumn 11, Issue 11, 2013, Pages 4419-4434

  Rubiolo, Juan A ^a   Ternon, Eva ^b   López Alonso, Henar ^a   Thomas, Olivier P ^b   Vega, Félix V ^a   Vieytes, Mercedes R ^a   Botana, Luis M ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b UNIVERSITÉ DE NICE SOPHIA ANTIPOLIS   (France)

Author keywords

Antifungal; Apoptosis; Cell cycle arrest; Crambescidine 816

Indexed keywords

CELL DNA; CRAMBESCIDIN 800; CRAMBESCIDIN 816; CRAMBESCIDIN 830; FUNGICIDE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL DEATH; CELL SIZE; CONTROLLED STUDY; DRUG POTENCY; DRUG STRUCTURE; G2 PHASE CELL CYCLE CHECKPOINT; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; SACCHAROMYCES CEREVISIAE;

SACCHAROMYCES CEREVISIAE;

ALKALOIDS; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL DEATH; CELL DIVISION; CELL SIZE; FUNGICIDES, INDUSTRIAL; G2 PHASE; GUANIDINE; MEMBRANE POTENTIAL, MITOCHONDRIAL; SACCHAROMYCES CEREVISIAE; SPIRO COMPOUNDS;

EID: 84889259179     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md11114419     Document Type: Article

References (41)

1. Laport, M.S.; Santos, O.C.; Muricy, G. Marine sponges: potential sources of new antimicrobial drugs. Curr. Pharm. Biotechnol. 2009, 10, 86-105.
2. Sagar, S.; Kaur, M.; Minneman, K.P. Antiviral lead compounds from marine sponges. Mar. Drugs 2010, 8, 2619-2638.
3. Abad, M.J.; Bedoya, L.M.; Bermejo, P. Marine Compounds and their Antimicrobial Activities. In Science against Microbial Pathogens: Communicating Current Research and Technological Advances; Méndez-Vilas, A., Ed.; FORMATEX: Badajoz, Spain, 2011.
4. Mayer, A.M.; Hamann, M.T. Marine pharmacology in 2001-2002: Marine compounds with anthelmintic, antibacterial, anticoagulant, antidiabetic, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems and other miscellaneous mechanisms of action. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2005, 140, 265-286.
5. Mayer, A.M.; Rodriguez, A.D.; Berlinck, R.G.; Hamann, M.T. Marine pharmacology in 2003-4: Marine compounds with anthelmintic antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2007, 145, 553-581.
6. Mayer, A.M.; Rodriguez, A.D.; Berlinck, R.G.; Hamann, M.T. Marine pharmacology in 2005-6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action. Biochim. Biophys. Acta 2009, 1790, 283-308.
7. Buscema, M.; Van de Vyver, G. Cytotoxic rejection of xenografts between marine sponges. J. Exp. Zool. 1985, 235, 297-308.
8. Burkholder, P.R.; Ruetzler, K. Antimicrobial activity of some marine sponges. Nature 1969, 222, 983-984.
9. Uriz, M.J.; Beccero, M.A.; Tur, J.M.; Turon, X. Location of toxicity within the Mediterranean sponge Crambe crambe. Mar. Biol. 1996, 124, 583-590.
10. Aron, Z.D.; Pietraszkiewicz, H.; Overman, L.E.; Valeriote, F.; Cuevas, C. Synthesis and anticancer activity of side chain analogs of the crambescidin alkaloids. Bioorg. Med. Chem. Lett. 2004, 14, 3445-3449.
11. Aoki, S.; Kong, D.; Matsui, K.; Kobayashi, M. Erythroid differentiation in K562 chronic myelogenous cells induced by crambescidin 800, a pentacyclic guanidine alkaloid. Anticancer Res. 2004, 24, 2325-2330.
12. Gassner, N.C.; Tamble, C.M.; Bock, J.E.; Cotton, N.; White, K.N.; Tenney, K.; St Onge, R.P.; Proctor, M.J.; Giaever, G.; Nislow, C.; et al. Accelerating the discovery of biologically active small molecules using a high-throughput yeast halo assay. J. Nat. Prod. 2007, 70, 383-390.
13. Berlinck, R.G.; Braekman, J.C.; Daloze, D.; Bruno, I.; Riccio, R.; Ferri, S.; Spampinato, S.; Speroni, E. Polycyclic guanidine alkaloids from the marine sponge Crambe crambe and Ca++ channel blocker activity of crambescidin 816. J. Nat. Prod. 1993, 56, 1007-1015.
14. Martin, V.; Vale, C.; Bondu, S.; Thomas, O.P.; Vieytes, M.R.; Botana, L.M. Differential Effects of Crambescins and Crambescidin 816 in Voltage-Gated Sodium, Potassium and Calcium Channels in Neurons. Chem. Res. Toxicol. 2013, in press.
15. Hughes, T.R. Yeast and drug discovery. Funct. Integr. Genomics 2002, 2, 199-211.
16. Pichler, S.; Piatti, S.; Nasmyth, K. Is the yeast anaphase promoting complex needed to prevent re-replication during G2 and M phases? EMBO J. 1997, 16, 5988-5997.
17. Endo, K.; Mizuguchi, M.; Harata, A.; Itoh, G.; Tanaka, K. Nocodazole induces mitotic cell death with apoptotic-like features in Saccharomyces cerevisiae. FEBS Lett. 2010, 584, 2387-2392.
18. Hartwell, L.H. Genetic control of the cell division cycle in yeast. IV. Genes controlling bud emergence and cytokinesis. Exp. Cell Res. 1971, 69, 265-276.
19. Cid, V.J.; Adamikova, L.; Cenamor, R.; Molina, M.; Sanchez, M.; Nombela, C. Cell integrity and morphogenesis in a budding yeast septin mutant. Microbiology 1998, 144, 3463-3474.
20. Longtine, M.S.; DeMarini, D.J.; Valencik, M.L.; Al-Awar, O.S.; Fares, H.; De Virgilio, C.; Pringle, J.R. The septins: Roles in cytokinesis and other processes. Curr. Opin. Cell Biol. 1996, 8, 106-119.
21. Howell, A.S.; Lew, D.J. Morphogenesis and the cell cycle. Genetics 2012, 190, 51-77.
22. Lew, D.J.; Reed, S.I. Cell cycle control of morphogenesis in budding yeast. Curr. Opin. Genet. Dev. 1995, 5, 17-23.
23. Rubiolo, J.A.; López-Alonso, H.; Roel, M.; Thomas, O.P.; Ternon, E.; Vieytes, M.R.; Vega, F.V.; Botana, L.M. Mechanism of cytotoxic action of crambescidin-816 on liver-derived tumour cell lines. Brit. J. Pharm. 2013, submitted for publication.
24. Wysocki, R.; Kron, S.J. Yeast cell death during DNA damage arrest is independent of caspase or reactive oxygen species. J. Cell Biol. 2004, 166, 311-316.
25. Madeo, F.; Herker, E.; Wissing, S.; Jungwirth, H.; Eisenberg, T.; Frohlich, K.U. Apoptosis in yeast. Curr. Opin. Microbiol. 2004, 7, 655-660.
26. van Engeland, M.; Nieland, L.J.; Ramaekers, F.C.; Schutte, B.; Reutelingsperger, C.P. Annexin V-affinity assay: A review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 1998, 31, 1-9.
27. Almeida, B.; Silva, A.; Mesquita, A.; Sampaio-Marques, B.; Rodrigues, F.; Ludovico, P. Drug-induced apoptosis in yeast. Biochim. Biophys. Acta 2008, 1783, 1436-1448.
28. Silva, M.T. Secondary necrosis: The natural outcome of the complete apoptotic program. FEBS Lett. 2010, 584, 4491-4499.
29. Desagher, S.; Osen-Sand, A.; Nichols, A.; Eskes, R.; Montessuit, S.; Lauper, S.; Maundrell, K.; Antonsson, B.; Martinou, J.C. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J. Cell Biol. 1999, 144, 891-901.
30. Korper, S.; Nolte, F.; Rojewski, M.T.; Thiel, E.; Schrezenmeier, H. The K+ channel openers diazoxide and NS1619 induce depolarization of mitochondria and have differential effects on cell Ca2+ in CD34+ cell line KG-1a. Exp. Hematol. 2003, 31, 815-823.
31. Narita, M.; Shimizu, S.; Ito, T.; Chittenden, T.; Lutz, R.J.; Matsuda, H.; Tsujimoto, Y. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc. Natl. Acad. Sci. USA 1998, 95, 14681-14686.
32. Giannattasio, S.; Atlante, A.; Antonacci, L.; Guaragnella, N.; Lattanzio, P.; Passarella, S.; Marra, E. Cytochrome c is released from coupled mitochondria of yeast en route to acetic acid-induced programmed cell death and can work as an electron donor and a ROS scavenger. FEBS Lett. 2008, 582, 1519-1525.
33. Ludovico, P.; Rodrigues, F.; Almeida, A.; Silva, M.T.; Barrientos, A.; Corte-Real, M. Cytochrome c release and mitochondria involvement in programmed cell death induced by acetic acid in Saccharomyces cerevisiae. Mol. Biol. Cell 2002, 13, 2598-2606.
34. Pereira, C.; Camougrand, N.; Manon, S.; Sousa, M.J.; Corte-Real, M. ADP/ATP carrier is required for mitochondrial outer membrane permeabilization and cytochrome c release in yeast apoptosis. Mol. Microbiol. 2007, 66, 571-582.
35. Sapienza, K.; Bannister, W.; Balzan, R. Mitochondrial involvement in aspirin-induced apoptosis in yeast. Microbiology 2008, 154, 2740-2747.
36. Smiley, S.T.; Reers, M.; Mottola-Hartshorn, C.; Lin, M.; Chen, A.; Smith, T.W.; Steele, G.D., Jr.; Chen, L.B. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc. Natl. Acad. Sci. USA 1991, 88, 3671-3675.
37. Barns, S.M.; Lane, D.J.; Sogin, M.L.; Bibeau, C.; Weisburg, W.G. Evolutionary relationships among pathogenic Candida species and relatives. J. Bacteriol. 1991, 173, 2250-2255.
38. Bondu, S.; Genta-Jouve, G.; Leirüs, M.; Vale, C.; Guigonis, J.-M.; Botana, L.M.; Thomas, O.P. Additional bioactive guanidine alkaloids from the Mediterranean sponge Crambe crambe. RSC Adv. 2012, 2, 2828-2835.
39. Tani, N.; Rahnasto-Rilla, M.; Wittekindt, C.; Salminen, K.A.; Ritvanen, A.; Ollakka, R.; Koskiranta, J.; Raunio, H.; Juvonen, R.O. Antifungal activities of novel non-azole molecules against S. cerevisiae and C. albicans. Eur. J. Med. Chem. 2012, 47, 270-277.
40. Madeo, F.; Frohlich, E.; Frohlich, K.U. A yeast mutant showing diagnostic markers of early and late apoptosis. J. Cell Biol. 1997, 139, 729-734.
41. Pina-Vaz, C.; Sansonetty, F.; Rodrigues, A.G.; Costa-Oliveira, S.; Tavares, C.; Martinez-de-Oliveira, J. Cytometric approach for a rapid evaluation of susceptibility of Candida strains to antifungals. Clin. Microbiol. Infect. 2001, 7, 609-618.